Exploring the nature of the interaction between human monoclonal antiphospholipid antibodies and domain I of ß2-glycoprotein I.

被引：0
|
作者：
Pericleous, Charis
Ioannou, Yiannis
Lambrianides, Anastasia
Chen, Pojen
Latchman, David
Isenberg, David
Rahman, Anisur
Giles, Ian
机构：
[1] UCL, London, England
[2] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S559 / S560
页数：2
相关论文
共 50 条
  • [21] β2-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome
    Bai, Aiping
    IMMUNOLOGY LETTERS, 2017, 186 : 15 - 19
  • [22] The critical role of arginine residues in the binding of human monoclonal antiphospholipid antibodies to β2glycoprotein I.
    Giles, I
    Lambrianides, N
    Ioannou, Y
    Latchman, D
    Chen, P
    Chukwuocha, R
    Isenberg, D
    Rahman, A
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S71 - S71
  • [23] OXIDATION OF β2-GLYCOPROTEIN I IS STRONGLY ASSOCIATED WITH THE PRESENCE OF ANTI-DOMAIN I ANTIBODIES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
    Raimondo, M. G.
    Pericleous, C.
    Radziszewska, A.
    Borghi, M. O.
    Meroni, P. L.
    Giles, I.
    Rahman, A.
    Ioannou, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 100 - 100
  • [24] The association between IgG and IgM antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis
    Filippidou, Natalia
    Krashias, George
    Pericleous, Charis
    Rahman, Anisur
    Ioannou, Yiannis
    Giles, Ian
    Demetriou, Christiana
    Anatolitou, Afroditi
    Christodoulou, Christina
    Pantzaris, Marios
    Lambrianides, Anastasia
    MOLECULAR IMMUNOLOGY, 2016, 75 : 161 - 167
  • [25] Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change
    de Laat, B
    Derksen, RHWM
    van Lummel, M
    Pennings, MTT
    de Groot, PG
    BLOOD, 2006, 107 (05) : 1916 - 1924
  • [26] The association between IgM and IgG antibodies against cardiolipin, β2-glycoprotein I and Domain I of β2-glycoprotein I with disease profile in patients with multiple sclerosis
    Filippidou, N.
    Krashias, G.
    Pericleous, C.
    Rahman, A.
    Giles, I.
    Ioannou, Y.
    Anatolitou, A.
    Christodoulou, C.
    Pantzaris, M.
    Lambrianides, A.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 444 - 445
  • [27] Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome
    Atsumi, T
    Tsutsumi, A
    Amengual, O
    Khamashta, MA
    Hughes, GRV
    Miyoshi, Y
    Ichikawa, K
    Koike, T
    RHEUMATOLOGY, 1999, 38 (08) : 721 - 723
  • [28] β2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of β2-glycoprotein I
    McNeeley, PA
    Dlott, JS
    Furie, RA
    Jack, RM
    Ortel, TL
    Triplett, DA
    Victoria, EJ
    Linnik, MD
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 590 - 595
  • [29] A role for the polymorphism at position 247 of the β2-glycoprotein I gene in the generation of anti-β2-glycoprotein I antibodies in the antiphospholipid syndrome
    Hirose, N
    Williams, R
    Alberts, AR
    Furie, RA
    Chartash, EK
    Jain, RI
    Sison, C
    Lahita, RG
    Merrill, JT
    Cucurull, E
    Gharavi, AE
    Sammaritano, LR
    Salmon, J
    Hashimoto, S
    Sawada, T
    Chu, CC
    Gregersen, PK
    Chiorazzi, N
    ARTHRITIS AND RHEUMATISM, 1999, 42 (08): : 1655 - 1661
  • [30] β2-glycoprotein I, the playmaker of the antiphospholipid syndrome
    de Laat, HB
    Derksen, RHWM
    de Groot, PG
    CLINICAL IMMUNOLOGY, 2004, 112 (02) : 161 - 168
12345